Novo Nordisk has taken legal action against Eli Lilly, accusing the American pharmaceutical giant of false advertising by suggesting its weight-loss treatments are superior to Novo’s products.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
